CompletedNCT00314535Updated Feb 25, 2016

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

An observational study in Healthy, sponsored by AHS Cancer Control Alberta. Completed at 1 site in Canada. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-25.

Sponsored by AHS Cancer Control Alberta · Observational

Study type: Observational
Model: Case-only
Time perspective: Retrospective
Enrollment: 40
Ages: 18 Years and older
Sex: Male

Study summary

Magnetic resonance (MR) spectroscopic techniques are to be developed to obtain the best data possible at 3 Tesla (3T) for the prostate.

Conditions studied

Healthy

In context

Lead sponsor

AHS Cancer Control Alberta is the lead sponsor of 182 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: Male
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Local Healthy Volunteers

Eligibility criteria

Inclusion Criteria:

Subject 18 years of age and over

Study design

Observational model: Case-only
Time perspective: Retrospective
Enrollment: 40 participants (actual)

Study locations

1 site

Cross Cancer Institute
Edmonton, Alberta T6G 1Z2, Canada

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Feb 25, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT00314535
Lead sponsor: AHS Cancer Control Alberta
Collaborators: Cross Cancer Institute
Responsible party: Sponsor
First posted: Apr 14, 2006
Start date: Jul 2005
Primary completion: Oct 2008
Completion: Oct 2008
Last update: Feb 25, 2016

Study contacts

Gino Fallone, PhD

principal investigator · AHS Cancer Control Alberta

Oversight

Data monitoring committee: Yes

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

AHS Cancer Control Alberta

Start the discussion